Kozta Adverse Reactions

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Full Prescribing Info

Adverse Reactions

Serious adverse reactions including pancreatitis and hypersensitivity reactions have been reported. Hypoglycemia has been reported in combination with sulfonylurea (4.7%-13.8%) and insulin (9.6%). Tabulated list of adverse reactions are listed as follows (Table 1) by system organ class and frequency.
Frequencies are defined as: very common (≥1/10); common (≥1/100 to <1/10); uncommon (≥1/1,000 to <1/100); rare (≥1/10,000 to <1/1,000); very rare (<1/10,000) and not known (cannot be estimated from the available data). (See Table.)

Click on icon to see table/diagram/image

View ADR Reporting Link

sitagliptin

Manufacturer:

Sai Mirra Innopharm

Distributor:

UNILAB, Inc

Marketer:

Westmont